Sponsors (14)
The bill would strengthen global health capacity—reducing pandemic risk and expanding access abroad while leveraging donor funds—but requires higher U.S. spending, complex diplomacy, and careful measures to avoid creating aid dependency in recipient countries.
Americans (the general public and taxpayers) would face lower pandemic risk and better domestic public-health protection as stronger health systems abroad and expanded access to diagnostics, treatments, and vaccines reduce the chance of global disease spread.
Low- and middle-income populations in recipient countries would gain increased access to diagnostics, treatments, and vaccines from modestly increased U.S. global health assistance, improving health outcomes abroad.
U.S. taxpayers could get greater value per dollar because stronger U.S. leadership on global health financing may leverage additional donor funding, multiplying the impact of U.S. contributions without a proportionate rise in U.S. outlays.
U.S. taxpayers could face higher federal spending if the United States increases global health aid as recommended.
Efforts to address structural economic injustices and expand global health financing may require complex diplomacy, trade or aid-policy changes that carry unforeseen costs and could provoke political resistance, slowing or complicating implementation.
Emphasis on donor-funded programs risks sustaining aid-dependent systems in recipient countries unless paired with durable domestic financing, creating sustainability risks and potential service gaps for low-income populations.
Based on analysis of 2 sections of legislative text.
Expresses findings and urges increased U.S. global health aid and action on structural economic drivers to reduce avoidable deaths; does not allocate funds or change law.
Introduced August 1, 2025 by Janice D. Schakowsky · Last progress August 1, 2025
Calls for greater U.S. attention and resources to strengthen health systems worldwide, memorializes Dr. Paul Farmer’s community-based approach, and highlights gaps in diagnostics, treatment, and vaccine access that drive avoidable deaths and pandemic risk. Notes large financing shortfalls in low- and lower-middle-income countries and argues modest U.S. increases in global health aid, together with action on structural economic drivers, could reduce preventable deaths and leverage additional donor funding. States facts and figures about current U.S. global health spending and international targets, emphasizes the limits of poorest countries’ domestic revenues, and urges addressing historical and structural economic injustices that hinder health outcomes. The text is a nonbinding statement of findings and views rather than a law that creates new spending or mandates.